These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11483334

  • 1. Potency after permanent prostate brachytherapy for localized prostate cancer.
    Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1235-42. PubMed ID: 11483334
    [Abstract] [Full Text] [Related]

  • 2. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate.
    Raina R, Agarwal A, Goyal KK, Jackson C, Ulchaker J, Angermeier K, Klein E, Ciezki J, Zippe CD.
    Urology; 2003 Dec 15; 62(6):1103-8. PubMed ID: 14665364
    [Abstract] [Full Text] [Related]

  • 6. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
    Potters L, Purrazzella R, Brustein S, Fearn P, Huang D, Leibel SA, Kattan MW.
    Int J Radiat Oncol Biol Phys; 2003 Jul 01; 56(3):749-54. PubMed ID: 12788181
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction.
    Merrick GS, Butler WM, Lief JH, Stipetich RL, Abel LJ, Dorsey AT.
    Urology; 1999 Jun 01; 53(6):1112-6. PubMed ID: 10367837
    [Abstract] [Full Text] [Related]

  • 8. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP.
    J Urol; 2007 Dec 01; 178(6):2521-5. PubMed ID: 17937948
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy.
    Potters L, Torre T, Ashley R, Leibel S.
    J Clin Oncol; 2000 Mar 01; 18(6):1187-92. PubMed ID: 10715287
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Quality of life after radiotherapy for prostate cancer].
    Joly F, Degrendel AC, Guizard AV.
    Cancer Radiother; 2010 Oct 01; 14(6-7):519-25. PubMed ID: 20728393
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M, Parker M, Guhring P, Mulhall JP.
    J Urol; 2005 Jul 01; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [Abstract] [Full Text] [Related]

  • 17. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity.
    Yoshioka Y, Nose T, Yoshida K, Oh RJ, Yamada Y, Tanaka E, Yamazaki H, Inoue T, Inoue T.
    Int J Radiat Oncol Biol Phys; 2003 May 01; 56(1):213-20. PubMed ID: 12694841
    [Abstract] [Full Text] [Related]

  • 18. Predictors of response to sildenafil citrate following radiation therapy for prostate cancer.
    Teloken PE, Parker M, Mohideen N, Mulhall JP.
    J Sex Med; 2009 Apr 01; 6(4):1135-1140. PubMed ID: 19210713
    [Abstract] [Full Text] [Related]

  • 19. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul 01; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 20. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.
    Urology; 2005 Jan 01; 65(1):95-100. PubMed ID: 15667872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.